US equities
|
SPCX
$168.25
▲+5.84%
NVDA
$237.26
▲+1.41%
MU
$1,067.05
▼-0.73%
TSLA
$377.44
▲+1.85%
MSFT
$526.19
▲+1.67%
INTC
$116.96
▼-1.99%
SNDK
$1,722.94
▲+0.17%
META
$745.37
▲+2.37%
SPCX
$168.25
▲+5.84%
NVDA
$237.26
▲+1.41%
MU
$1,067.05
▼-0.73%
TSLA
$377.44
▲+1.85%
MSFT
$526.19
▲+1.67%
INTC
$116.96
▼-1.99%
SNDK
$1,722.94
▲+0.17%
META
$745.37
▲+2.37%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Annexon, Inc. - common stock
(NQ:
ANNX
)
4.135
-0.055 (-1.31%)
Delayed Quote
Updated: 11:04 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Annexon, Inc. - common stock
< Previous
1
2
3
4
5
6
7
8
Next >
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
March 26, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
March 22, 2024
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.
Via
Benzinga
Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday
↗
March 22, 2024
U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.
Via
Benzinga
Topics
Stocks
Recap: Annexon Q3 Earnings
↗
November 13, 2023
Via
Benzinga
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
March 18, 2024
From
Annexon Biosciences
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
March 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
March 13, 2024
Via
Benzinga
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
March 13, 2024
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...
Via
Benzinga
Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach
February 21, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
February 20, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session
↗
January 08, 2024
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 150 points on Monday. Shares of Harpoon Therapeutics, Inc.(NASDAQ: HARP) rose sharply in pre-market trading....
Via
Benzinga
Topics
Stocks
Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement Portfolio for Autoimmune, Ophthalmic and Neurodegenerative Diseases
January 07, 2024
From
Annexon Biosciences
Via
GlobeNewswire
$1M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
↗
December 29, 2023
The Dow Jones index closed higher by over 50 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Annexon Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Nasdaq Gains 100 Points; CarMax Earnings Top Views
↗
December 21, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.37% to 37,218.15 while the NASDAQ rose 0.73% to 14,885.76....
Via
Benzinga
Topics
Stocks
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
December 21, 2023
Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.
Via
Benzinga
Why Is Complement-Mediated Focused Annexon Stock Trading Higher Today?
↗
December 21, 2023
On Wednesday, Annexon Inc (NASDAQ: ANNX) reported results from the Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) healthy volunteer study of ANX1502 that targets the active form...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
December 21, 2023
It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!
Via
InvestorPlace
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
December 20, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint
December 20, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Phase 1 Results for ANX1502, its Oral Small Molecule Inhibitor of the Classical Complement Pathway
December 20, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
December 18, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference
November 22, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results
November 13, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Biosciences to Participate in 2023 Jefferies London Healthcare Conference
November 09, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Receives PRIME Designation from the EMA for ANX007 for the Treatment of Geographic Atrophy
October 24, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
October 18, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Announces Clinical and Regulatory Progress for ANX005 Pivotal Program in Guillain-Barré Syndrome (GBS)
October 10, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Biosciences to Participate in the 2023 Cantor Global Healthcare Conference
September 19, 2023
From
Annexon Biosciences
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
